Newsroom

Sorted by: Latest
-

First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds ICAV

LONDON--(BUSINESS WIRE)--First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the distributions for the following sub-funds of First Trust Global Funds ICAV, ISIN Fund Name Frequency Dividend per Share IE00BWTNMB87 First Trust US Large Cap Core AlphaDEX® UCITS ETF Class B Quarterly $0.1637 (USD) IE00BWTNM966 First Trust Germany AlphaDEX® UCITS ETF Class A Quarterly 0.5579 (EUR) IE00BZBW4Z27 First Trust US Equity Income UCITS ETF Class A Quarterly $0.2978 (USD)...
-

Latest Analysis of Imperative Care’s SYMPHONY-PE Trial Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism

CAMPBELL, Calif.--(BUSINESS WIRE)--Latest analysis of Imperative Care’s SYMPHONY-PE trial suggests early thrombectomy may improve key measures of heart recovery in intermediate-risk PE....
-

PICS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The case alleges that the IPO’s offering documents contained misleading statements and/or omitted material information....
-

Rosen Law Firm Urges Embecta Corp. (NASDAQ: EMBC) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026. Embecta describes itself as a “leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Al...
-

Resumen: BioIVT presentará sus soluciones y experiencia ADME-Tox en los principales eventos del sector este verano

WOODBURY, Nueva York--(BUSINESS WIRE)--BioIVT, proveedor líder de soluciones de muestras biológicas y socio global de investigación para el desarrollo de fármacos y diagnósticos, anunció hoy que dará a conocer su amplia oferta de soluciones ADME-Tox y sus capacidades científicas en algunos de los principales encuentros del sector, entre ellos la MPS World Summit 2026 y la 16.a Reunión Europea de la ISSX. La MPS World Summit se celebrará del 26 al 29 de mayo de 2026 en Washington D. C. Los exper...
-

Samenvatting: BioIVT presenteert ADME-Tox-expertise en -oplossingen tijdens evenementen in de zomer van 2026

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, de toonaangevende leverancier van biospecimenoplossingen en wereldwijde onderzoekspartner voor de ontwikkeling van geneesmiddelen en diagnostiek, heeft vandaag aangekondigd dat het zijn brede portfolio aan ADME-Tox-oplossingen en onderzoeksexpertise zal presenteren op verschillende toonaangevende branche-evenementen, waaronder de MPS World Summit 2026 en de 16e Europese ISSX-bijeenkomst. De MPS World Summit vindt plaats van 26 t/m 29 mei 2026 in Washingt...
-

Riassunto: BioIVT presenterà l'esperienza e le soluzioni ADME-Tox agli eventi estivi 2026

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, il principale fornitore di soluzioni per campioni biologici e partner globale nella ricerca per lo sviluppo farmaceutico e diagnostico, oggi ha annunciato che presenterà il suo ampio portafoglio di soluzioni ADME-Tox e di competenze di ricerca nell'ambito di vari importanti eventi nel settore, tra cui il 2026 MPS World Summit e ISSX 16th European Meeting. L'MPS World Summit si svolge dal 26 al 29 maggio 2026 a Washington, D.C. I colleghi di BioIVT sarann...
-

BioIVT präsentiert seine ADME-Tox-Kompetenz und -Lösungen auf Veranstaltungen im Sommer 2026

WOODBURY, New York--(BUSINESS WIRE)--BioIVT, der führende Anbieter von Bioprobenlösungen und globaler Forschungspartner für die Arzneimittel- und Diagnostikaentwicklung, gab heute bekannt, dass es sein breites Portfolio an ADME-Tox-Lösungen und seine Forschungskompetenz auf mehreren führenden Branchenveranstaltungen präsentieren wird, darunter der 2026 MPS World Summit und das 16. Europäische Treffen der ISSX. Der MPS World Summit findet vom 26. bis 29. Mai 2026 in Washington, D.C., statt. Mita...
-

BioIVT mettra en avant son expertise et ses solutions en matière d'ADME-Tox lors des manifestations estivales de 2026

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, leader dans la fourniture de solutions pour les échantillons biologiques et partenaire mondial de recherche pour le développement de médicaments et de diagnostics, a annoncé aujourd’hui qu’il présenterait sa vaste gamme de solutions ADME-Tox ainsi que son expertise en recherche lors de plusieurs événements majeurs du secteur, notamment le 2026 MPS World Summit et la 16e réunion européenne de l’ISSX . Le MPS World Summit se tiendra du 26 au 29 mai 2026 à...
-

Rehlko e Liebherr collaborano all'espansione strategica delle capacità per supportare la crescente domanda di data center per soluzioni di alimentazione resiliente

MILWAUKEE--(BUSINESS WIRE)--Rehlko, un leader globale in ambito di resilienza energetica che offre soluzioni innovative nei sistemi energetici industriali, nelle tecnologie dei gruppi propulsori e nelle applicazioni energetiche domestiche, si è unita a Liebherr Group (“Liebherr”) il 2 giugno alla cerimonia di inaugurazione dell'espansione strategica della capacità presso lo stabilimento di Liebherr-Components a Colmar, Franciae. Questo evento segna un traguardo storico nella continua espansione...